Israel Englander’s Aridis Pharmaceuticals Inc. Common Stock ARDS Stock Holding History

Israel Englander’s Portfolio ARDS Stock Details ARDS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-74,559	Closed	-$274K	–	7598
2021 Q3	$274K	Buy	+74,559	New	+$345K	﹤0.01%	5881
2020 Q4	–	Sell	-11,329	Closed	-$80	–	5714
2020 Q3	$80	Buy	11,329 +124	+1%	+$864	﹤0.01%	4253
2020 Q2	$74K	Buy	11,205 +802	+8%	+$5.54K	﹤0.01%	4015
2020 Q1	$60K	Sell	10,403 -1,043	-9%	-$6.65K	﹤0.01%	3643
2019 Q4	$51K	Sell	11,446 -14,123	-55%	-$74.5K	﹤0.01%	4097
2019 Q3	$171K	Buy	+25,569	New	+$234K	﹤0.01%	3834
2019 Q2	–	Sell	-10,763	Closed	-$118K	–	4610
2019 Q1	$118K	Sell	10,763 -1,349	-11%	-$12.5K	﹤0.01%	3825
2018 Q4	$134K	Sell	12,112 -11,473	-49%	-$131K	﹤0.01%	3505
2018 Q3	$306K	Buy	+23,585	New	+$305K	﹤0.01%	3477

Other funds holding ARDS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RAM

Roumell Asset Management Chevy Chase, Maryland $53.3M AUM 8.91% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

PCM

Perritt Capital Management Chicago, Illinois $59.8M AUM 26.94% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Israel Englander's ARDS Position: Q4 2021 in Review

Israel Englander sold out of Aridis Pharmaceuticals Inc. Common Stock (ARDS) in Q4 2021, closing a stake of 74,559 shares — an estimated $274K sold.

Israel Englander first reported a position in ARDS in Q3 2018 and held it in 9 quarters. The position peaked at $306K in Q3 2018. 20 funds tracked by Wall St. Rank hold ARDS as of Q4 2021.

Israel Englander reported no remaining Aridis Pharmaceuticals Inc. Common Stock position as of Q4 2021 after selling out during the quarter.
Israel Englander sold 74,559 Aridis Pharmaceuticals Inc. Common Stock shares in Q4 2021, an estimated $274K.
Israel Englander first reported a position in Aridis Pharmaceuticals Inc. Common Stock in Q3 2018 and held it in 9 quarters.
Israel Englander's Aridis Pharmaceuticals Inc. Common Stock position peaked at $306K in Q3 2018.
20 funds tracked by Wall St. Rank held Aridis Pharmaceuticals Inc. Common Stock as of Q4 2021.

Based on Millennium Management's 13F filing for Q4 2021, filed 14 Feb 2022.